Thursday, February 20, 2025, 10:41PM |  22°
MENU
Advertisement
1
MORE

Highmark joins other Blue plans in making generic drugs

Bob Donaldson

Highmark joins other Blue plans in making generic drugs

Highmark is among 18 Blue Cross Blue Shield health insurance plans that are investing $55 million to create cheaper versions of expensive generic drugs for consumers. The initiative will begin by producing seven to 10 generic drugs and make them available by early 2022.

The drugs were not identified for competitive reasons.

Downtown-based Highmark is a founding member of a new unnamed subsidiary of Civica Rx, which is designed to preserve member access to affordable retail generic prescription drugs. Civica Rx, a nonprofit generic drugmaker based in Salt Lake City, Utah, was formed in 2018 and has focused on alleviating prescription drug shortages in hospitals.

Advertisement

The new Civica subsidiary — also a nonprofit — will focus the consumer side, assuring the availability of low-cost generics for Blue members. 

“Generics have historically been the low-cost option, but select generics have not been low cost,” said Sarah Marche, senior vice president of pharmacy services at Highmark. “On the consumer side, it’s been more about high cost rather than shortages for all sorts of disease states.”

Members will pick up the prescriptions at participating pharmacies and through the health plan’s mail order service, Ms. Marche said. At first, the Civica subsidiary will contract with drug manufacturers to make the needed generics, but the long-term plan is to bring the drug-making capability in-house with its own production facility.

Highmark’s Allegheny Health Network was a founding member of Civica Rx’s hospital initiative and the typical drug that hospitals have trouble finding is a generic sterile injectable, according to Civica. Antibiotics, pain and anesthesia medications, and chemotherapy drugs have all experienced shortages, which have cost health systems an estimated $230 million in spending on more expensive substitutes.

Advertisement

Generic drug market dynamics fuel some of the drug shortages. After a prescription drug loses patent protection, intense price competition drives down prices, lowering margins and providing little incentive for manufacturers to enter or stay in the generics market.

In other instances, entrepreneurs and drug companies buy up off-patent drugs that had no competition before sharply raising prices.

Kris B. Mamula: kmamula@post-gazette.com or 412-263-1699

First Published: January 23, 2020, 3:42 p.m.

RELATED
SHOW COMMENTS (0)  
Join the Conversation
Commenting policy | How to Report Abuse
If you would like your comment to be considered for a published letter to the editor, please send it to letters@post-gazette.com. Letters must be under 250 words and may be edited for length and clarity.
Partners
Advertisement
Longtime KDKA-TV host Jon Burnett on May 22, 2019.
1
a&e
Jon Burnett, long a KDKA-TV staple, leaves legacy of ‘putting good out into the world’
Pennsylvania Gov. Josh Shapiro delivers his budget address for the 2025-26 fiscal year  at the Capitol, Feb. 4,  in Harrisburg, Pa.
2
news
Trump taps Shapiro to join bipartisan governor's council
WASHINGTON, DC - FEBRUARY 6:  U.S. Sen. John Fetterman (D-PA) speaks to a reporter following a vote to confirm Russell Vought as director of the Office of Management and Budget on February 6, 2025 in Washington, DC. The Senate will continue to vote into the night to proceed to the confirmation of the remaining Trump cabinet nominees. (Photo by Anna Rose Layden/Getty Images)
3
news
Pair of John Fetterman's staffers reportedly leaving senator's office
The Breezewood Interchange is dotted with gas stations, chain restaurants and souvenir shops. The Pennsylvania Turnpike Commission has selected Chicago-based Alfred Benesch and Company to spearhead a major redesign of the notorious roadway.
4
business
So long, Breezewood: Chicago firm selected to redesign infamous Pa. Turnpike interchange
Dr. Sylvia Owusu-Ansah helped writers of "The Pitt" with her perspective working in emergency medicine.
5
a&e
'It's very real,' says the Pittsburgh ER doctor who consulted on 'The Pitt' TV show
 (Bob Donaldson)
Bob Donaldson
Advertisement
LATEST business
Advertisement
TOP
Email a Story